STOCK TITAN

Hewlett Packard Enterprise names Frank D’Amelio, former CFO of Pfizer Inc., to Board of Directors

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags
management
Rhea-AI Summary

Hewlett Packard Enterprise (NYSE: HPE) appointed Frank D’Amelio to its Board of Directors, effective immediately. D’Amelio, a former CFO at Pfizer, brings over 40 years of experience in finance and operations, with a proven track record of market-cap growth, including a $165 billion increase during his tenure at Pfizer. He will also serve on the Board's Audit Committee. D’Amelio stated his excitement to join HPE amid its transformation strategy and emphasized the company's edge-to-cloud positioning.

Positive
  • Frank D’Amelio's extensive experience in finance and operations may enhance HPE's strategic direction.
  • D'Amelio's proven leadership in managing large-scale transformations could drive performance improvements.
  • His insights into IT management may strengthen HPE’s customer engagement and service delivery.
Negative
  • Concerns may arise about potential experience gaps in the Board due to new member integration.

D’Amelio joins HPE Board with more than 40 years of leadership experience across finance and operations

HOUSTON--(BUSINESS WIRE)-- Hewlett Packard Enterprise (NYSE: HPE) today announced that Frank D’Amelio, former executive vice president and CFO of Pfizer Inc., has been appointed to HPE’s Board of Directors, effective today. D’Amelio will also serve as a member of the Board’s Audit Committee.

D’Amelio’s expertise and proven leadership in finance, corporate development, and operations across multiple industries will bring additional valuable perspective to the Board, and his experience managing IT will lend a relevant customer lens to his insights.

“Frank has an impressive track record of driving a strategic vision for companies’ financial success and guiding large-scale transformations,” said Patricia Russo, chair of the Board of Directors, Hewlett Packard Enterprise. “HPE will benefit from his executive leadership experience and deep expertise across finance, corporate development, operations, IT, and supply chain as the company continues to drive performance and increase market differentiation.”

D’Amelio is a distinguished leader who has been regularly named one of America’s top CFOs. During his tenure as CFO at Pfizer, he was instrumental in leading a multi-year transformation and increased the company’s market capitalization by approximately $165 billion. In addition to his role as CFO at Pfizer, D’Amelio was also responsible for Global Supply from 2018 to 2021, which included the manufacturing and distribution of the COVID-19 vaccine.

Prior to joining the healthcare sector at Pfizer, D’Amelio worked in senior executive roles in the communications industry, including serving as Chief Operating Officer, Chief Administrative Officer, and Chief Financial Officer during his tenure at Lucent Technologies, Inc., which merged with Alcatel S.A. in 2006 to form Alcatel-Lucent.

“HPE’s differentiated edge-to-cloud strategy and portfolio are well-positioned to meet the needs of customers and continue to propel the company’s transformation and success,” D’Amelio said. “I am delighted to join the Board during this exciting period as HPE accelerates its leadership.”

D’Amelio also currently serves as a board director for Humana, Inc. and Zoetis, Inc.

About Hewlett Packard Enterprise

Hewlett Packard Enterprise (NYSE: HPE) is the global edge-to-cloud company that helps organizations accelerate outcomes by unlocking value from all of their data, everywhere. Built on decades of reimagining the future and innovating to advance the way people live and work, HPE delivers unique, open and intelligent technology solutions as a service. With offerings spanning Cloud Services, Compute, High Performance Computing & AI, Intelligent Edge, Software, and Storage, HPE provides a consistent experience across all clouds and edges, helping customers develop new business models, engage in new ways, and increase operational performance. For more information, visit: www.hpe.com.

Forward-looking Statement

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements involve risks, uncertainties, and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of Hewlett Packard Enterprise Company and its consolidated subsidiaries ("Hewlett Packard Enterprise") may differ materially from those expressed or implied by such forward-looking statements and assumptions. The words “believe,” “expect,” “anticipate,” “intend,” “will,” "may," and similar expressions are intended to identify such forward-looking statements. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of HPE may differ materially from those expressed or implied by such forward-looking statements and assumptions. All statements other than statements of historical fact are statements that could be deemed forward-looking statements, including but not limited to any projections of financial performance, plans, strategies and objectives of management for future operations or performance. Risks, uncertainties and assumptions include those that are described in HPE’s Annual Report on Form 10-K for the fiscal year ended October 31, 2022, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and that are otherwise described or updated from time to time in Hewlett Packard Enterprise’s Securities and Exchange Commission reports. Hewlett Packard Enterprise assumes no obligation and does not intend to update these forward-looking statements, except as required by applicable law.

Slgi Jolissaint

slgi.jolissaint@hpe.com

Source: Hewlett Packard Enterprise

FAQ

Who is Frank D’Amelio and what is his experience?

Frank D’Amelio is the former CFO of Pfizer, with over 40 years of leadership in finance and operations.

What is the significance of D’Amelio joining the HPE Board?

D’Amelio brings valuable insights with his experience in large-scale transformations and financial strategy.

What role will D’Amelio play at HPE?

D’Amelio will serve on HPE's Board of Directors and the Audit Committee.

How might D’Amelio's appointment impact HPE?

His appointment may enhance HPE’s strategic focus and operational performance.

When did D’Amelio join HPE's Board?

Frank D’Amelio joined HPE's Board of Directors effective immediately upon the announcement.

Hewlett Packard Enterprise Company

NYSE:HPE

HPE Rankings

HPE Latest News

HPE Stock Data

28.79B
1.29B
0.4%
86.16%
2.55%
Communication Equipment
Computer & Office Equipment
Link
United States of America
SPRING